In the study of Ireland and colleagues, the blockade of GAS6 using warfarin in pancreatic models further revealed that inhibition of the GAS6/AXL axis could reduce cancer cell plasticity, activate NK cells and inhibit pancreatic cancer metastasis (157). This evidence concerns the gene AXL and pancreatic neoplasm.